Click here to skip to this page's main content.

New to the Open Library? — Learn how it works
Last edited by LC Bot
November 16, 2011 | History

Advancing regulatory science for medical countermeasure development 1 edition

Advancing regulatory science for medical countermeasure development
Theresa M. Wizemann

Read

No readable version available.

Buy

Amazon
Better World Books $9.09 (used)

Lists

You could add Advancing regulatory science for medical countermeasure development to a list if you log in.

Links (leaves Open Library)

There is only 1 edition record, so we'll show it here...  •  Add edition?

Advancing regulatory science for medical countermeasure development
workshop summary
Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation ; Forum on Medical and Public Health Preparedness for Catastropic Events, Board on Health Sciences Policy, Institute of Medicine of the National Academies

Published 2011 by Natlional Academies Press in Washington, D.C .
Written in English.

About the Book

Whether or not the United States has safe and effective medical countermeasures--such as vaccines, drugs, and diagnostic tools--available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing regulatory science for medical countermeasure development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing regulatory science for medical countermeasure development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations"--Publisher's description.

Edition Notes

Includes bibliographical references (p. 81-82).

Also available online in Open Book format via the National Academies Press home page.

Classifications

Library of Congress
RA645.5 .A287 2011

The Physical Object

Pagination
xviii, 132 p. :
Number of pages
132

ID Numbers

Open Library
OL25104223M
ISBN 10
0309214904
ISBN 13
9780309214902
LC Control Number
2011499600
OCLC/WorldCat
744284130

History Created November 16, 2011 · 1 revision Download catalog record: RDF / JSON

November 16, 2011 Created by LC Bot import new book